Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells
Aixin Yu, Linjian Zhu, Norman H. Altman, et al.
Immunity (2009) Vol. 30, Iss. 2, pp. 204-217
Open Access | Times Cited: 254

Showing 1-25 of 254 citing articles:

Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
Immunity (2009) Vol. 30, Iss. 5, pp. 636-645
Open Access | Times Cited: 1699
The role of interleukin-2 during homeostasis and activation of the immune system
Onur Boyman, Jonathan Sprent
Nature reviews. Immunology (2012) Vol. 12, Iss. 3, pp. 180-190
Closed Access | Times Cited: 1501
Regulatory T Cells and Human Disease
Shimon Sakaguchi, Norihisa Mikami, James B. Wing, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 541-566
Closed Access | Times Cited: 841
Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
Thomas R. Malek, Iris Castro
Immunity (2010) Vol. 33, Iss. 2, pp. 153-165
Open Access | Times Cited: 767
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing, Atsushi Tanaka, Shimon Sakaguchi
Immunity (2019) Vol. 50, Iss. 2, pp. 302-316
Open Access | Times Cited: 588
Treg cell-based therapies: challenges and perspectives
Caroline Raffin, Linda T. Vo, Jeffrey A. Bluestone
Nature reviews. Immunology (2019) Vol. 20, Iss. 3, pp. 158-172
Open Access | Times Cited: 544
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
David Klatzmann, Abul K. Abbas
Nature reviews. Immunology (2015) Vol. 15, Iss. 5, pp. 283-294
Closed Access | Times Cited: 542
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
Markus Feuerer, Jonathan A. Hill, Diane Mathis, et al.
Nature Immunology (2009) Vol. 10, Iss. 7, pp. 689-695
Closed Access | Times Cited: 497
Homeostatic control of regulatory T cell diversity
Adrian Liston, Daniel H.D. Gray
Nature reviews. Immunology (2014) Vol. 14, Iss. 3, pp. 154-165
Closed Access | Times Cited: 409
Nuclear Factor-κB Modulates Regulatory T Cell Development by Directly Regulating Expression of Foxp3 Transcription Factor
Meixiao Long, Sung‐Gyoo Park, Ian Strickland, et al.
Immunity (2009) Vol. 31, Iss. 6, pp. 921-931
Open Access | Times Cited: 367
An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
Claudio Procaccini, Veronica De Rosa, Mario Galgani, et al.
Immunity (2010) Vol. 33, Iss. 6, pp. 929-941
Open Access | Times Cited: 345
Interleukin-2: Biology, Design and Application
Natalia Arenas-Ramirez, Janine Woytschak, Onur Boyman
Trends in Immunology (2015) Vol. 36, Iss. 12, pp. 763-777
Open Access | Times Cited: 319
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj, et al.
The Lancet (2013) Vol. 381, Iss. 9884, pp. 2167-2175
Closed Access | Times Cited: 279
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
S. Alice Long, Karen Cerosaletti, Paul L. Bollyky, et al.
Diabetes (2009) Vol. 59, Iss. 2, pp. 407-415
Open Access | Times Cited: 270
Regulatory T cells in the treatment of disease
Amir Sharabi, Maria Tsokos, Ying Ding, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 11, pp. 823-844
Open Access | Times Cited: 265
T cells as therapeutic targets in SLE
José C. Crispín, Vasileios C. Kyttaris, Cox Terhorst, et al.
Nature Reviews Rheumatology (2010) Vol. 6, Iss. 6, pp. 317-325
Open Access | Times Cited: 255
CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice
Christian Weber, Svenja Meiler, Yvonne Döring, et al.
Journal of Clinical Investigation (2011) Vol. 121, Iss. 7, pp. 2898-2910
Open Access | Times Cited: 253
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Valeria Quarona, Gianluca Zaccarello, Antonella Chillemi, et al.
Cytometry Part B Clinical Cytometry (2013) Vol. 84B, Iss. 4, pp. 207-217
Open Access | Times Cited: 252
Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases
Naganari Ohkura, Shimon Sakaguchi
Cell Research (2020) Vol. 30, Iss. 6, pp. 465-474
Open Access | Times Cited: 243
Treatment strategies for autoimmune encephalitis
Yong‐Won Shin, Soon‐Tae Lee, Kyung‐Il Park, et al.
Therapeutic Advances in Neurological Disorders (2017) Vol. 11
Open Access | Times Cited: 241
Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation—Lessons From Rheumatoid Arthritis
Karine Chemin, Christina Gerstner, Vivianne Malmström
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 189
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
James B. Wing, Yohko Kitagawa, Michela Locci, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 31
Open Access | Times Cited: 185
Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
Aixin Yu, Isaac Snowhite, Francesco Vendrame, et al.
Diabetes (2015) Vol. 64, Iss. 6, pp. 2172-2183
Open Access | Times Cited: 180
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
Eleonora Trotta, Paul Bessette, Stephanie Silveria, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1005-1014
Open Access | Times Cited: 174
Treg cells in autoimmunity: from identification to Treg-based therapies
Lisa Göschl, Clemens Scheinecker, Michael Bonelli
Seminars in Immunopathology (2019) Vol. 41, Iss. 3, pp. 301-314
Closed Access | Times Cited: 165
Page 1 - Next Page

Scroll to top